WallStreetZenWallStreetZen

NASDAQ: NERV
Minerva Neurosciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for NERV

Based on 1 analyst offering 12 month price targets for Minerva Neurosciences Inc

Min Forecast
$5.00+177.78%
Avg Forecast
$5.00+177.78%
Max Forecast
$5.00+177.78%

Should I buy or sell NERV stock?

Based on 1 analyst offering ratings for Minerva Neurosciences Inc.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their NERV stock forecasts and price targets.

NERV stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-02-26

1 of 1

Forecast return on equity

Is NERV forecast to generate an efficient return?

Company
-38.87%
Industry
140.91%
Market
90.47%
NERV's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NERV forecast to generate an efficient return on assets?

Company
34.54%
Industry
32.45%
NERV is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NERV earnings per share forecast

What is NERV's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$2.68-426.83%

NERV vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
NERV$1.80$5.00+177.78%Hold
BRTX$1.68N/AN/A
ICU$1.18N/AN/A
EQ$0.35$1.00+188.18%Hold
NEUP$6.82$21.00+208.10%Buy
View Top Biotech Stocks

Minerva Neurosciences Stock Forecast FAQ

Is Minerva Neurosciences Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: NERV) stock is to Hold NERV stock.

Out of 1 analyst, 0 (0%) are recommending NERV as a Strong Buy, 0 (0%) are recommending NERV as a Buy, 1 (100%) are recommending NERV as a Hold, 0 (0%) are recommending NERV as a Sell, and 0 (0%) are recommending NERV as a Strong Sell.

If you're new to stock investing, here's how to buy Minerva Neurosciences stock.

What is NERV's earnings growth forecast for 2025-2025?

(NASDAQ: NERV) Minerva Neurosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.6%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.33%.

Minerva Neurosciences's earnings in 2025 is $6,254,698.

In 2025, NERV is forecast to generate -$18,742,328 in earnings, with the lowest earnings forecast at -$18,742,328 and the highest earnings forecast at -$18,742,328.

What is NERV's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: NERV) forecast ROE is -38.87%, which is considered weak.

What is NERV's Price Target?

According to 1 Wall Street analyst that have issued a 1 year NERV price target, the average NERV price target is $5.00, with the highest NERV stock price forecast at $5.00 and the lowest NERV stock price forecast at $5.00.

The Wall Street analyst predicted that Minerva Neurosciences's share price could reach $5.00 by Feb 26, 2026. The average Minerva Neurosciences stock price prediction forecasts a potential upside of 177.78% from the current NERV share price of $1.80.

What is NERV's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: NERV) Minerva Neurosciences's current Earnings Per Share (EPS) is $0.82. In 2025, NERV's EPS is forecast to hit -$2.68 (min: -$2.68, max: -$2.68).

What is NERV's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: NERV) forecast ROA is 34.54%, which is higher than the forecast US Biotechnology industry average of 32.45%.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.